Education
About Us
Working with TipRanks
Follow Us
Eli Lilly & Co (DE:LLY)
XETRA:LLY
LLY Stock Chart & Stats
Day’s Range― - ―
52-Week Range€657.50 - €888.30
Previous CloseN/A
Volume143.00
Average Volume (3M)3.60K
Market Cap
$724.58B
Enterprise Value€761.80B
Total Cash (Recent Filing)$2.46B
Total Debt (Recent Filing)$16.51B
Price to Earnings (P/E)74.0
Beta0.12
Next Earnings
May 01, 2025EPS Estimate
4.31Last Dividend Ex-Date
Feb 14, 2025Dividend Yield0.62%
Share Statistics
EPS (TTM)10.67
Shares Outstanding947,989,140
10 Day Avg. Volume4,763
30 Day Avg. Volume3,597
Financial Highlights & Ratios
PEG Ratio0.72
Price to Book (P/B)N/A
Price to Sales (P/S)18.31
Price to Cash Flow (P/CF)83.30
P/FCF Ratio210.80
Enterprise Value/Market Cap1.05
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit20.80
Enterprise Value/Ebitda48.75
Forecast
1Y Price Target
€947.81Price Target Upside21.70% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering18
---
Bulls Say, Bears Say
Bulls Say
Clinical TrialsThe company is expected to release data from its Orfoglipron Phase 3 trials, which could influence the stock positively.
Market StrategyThe launch of Zepbound vials through a self-pay program and lowering the price of existing vials could help Eli Lilly take market share from GLP-1 compounding, which is a significant part of the market.
Bears Say
Market PenetrationZepbound vials make up a low/mid-single-digit percentage of total scripts, signaling limited market penetration.
---
Options Prices
Currently, No data available
---
Ownership Overview
10.34% Insiders
22.57% Mutual Funds
25.88% Other Institutional Investors
25.34% Public Companies and Individual Investors
LLY FAQ
What was Eli Lilly & Co’s price range in the past 12 months?
Eli Lilly & Co lowest stock price was €657.50 and its highest was €888.30 in the past 12 months.
What is Eli Lilly & Co’s market cap?
Eli Lilly & Co’s market cap is $724.58B.
When is Eli Lilly & Co’s upcoming earnings report date?
Eli Lilly & Co’s upcoming earnings report date is May 01, 2025 which is in 51 days.
How were Eli Lilly & Co’s earnings last quarter?
Eli Lilly & Co released its earnings results on Feb 06, 2025. The company reported €4.9 earnings per share for the quarter, beating the consensus estimate of €4.646 by €0.253.
Is Eli Lilly & Co overvalued?
According to Wall Street analysts Eli Lilly & Co’s price is currently Undervalued.
Does Eli Lilly & Co pay dividends?
Eli Lilly & Co pays a Quarterly dividend of €4.971 which represents an annual dividend yield of 0.62%. See more information on Eli Lilly & Co dividends here
What is Eli Lilly & Co’s EPS estimate?
Eli Lilly & Co’s EPS estimate is 4.31.
How many shares outstanding does Eli Lilly & Co have?
Eli Lilly & Co has 947,989,140 shares outstanding.
What happened to Eli Lilly & Co’s price movement after its last earnings report?
Eli Lilly & Co reported an EPS of €4.9 in its last earnings report, beating expectations of €4.646. Following the earnings report the stock price went up 5.851%.
Which hedge fund is a major shareholder of Eli Lilly & Co?
Currently, no hedge funds are holding shares in DE:LLY
---
Eli Lilly & Co Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€947.81 (21.70% Upside)
€947.81 (21.70% Upside)
Blogger Sentiment
Bullish
DE:LLY Sentiment 85%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $2.2B over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
9.57%
12-Months-Change
Fundamentals
Return on Equity
84.84%
Trailing 12-Months
Asset Growth
22.98%
Trailing 12-Months
Company Description
Eli Lilly & Co
Founded in 1876, Eli Lilly & Co. is a leading healthcare company that manufactures and sells pharmaceutical products worldwide. The company is headquartered in Indianapolis, Indiana.
---
LLY Company Deck
---
LLY Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant revenue growth and successful product launches, underpinned by strategic investments and advancements in the pipeline. However, challenges such as pricing pressures, a decline in Trulicity revenue, and supply constraints in certain regions tempered the overall positive outlook.Read More>---
LLY Revenue Breakdown
67.44% U.S.
15.36% Europe
9.48% ROW
4.03% Japan
3.69% China
---
LLY Stock 12 Month Forecast
Average Price Target
€947.81
▲(21.70% Upside)
Technical Analysis
Best Analysts Covering LLY
1 Year
1 Year Success Rate
39/42 ratings generated profit
1 Year Average Return
+37.81%
reiterated a buy rating last month
Copying David Risinger's trades and holding each position for 1 Year would result in 92.86% of your transactions generating a profit, with an average return of +37.81% per trade.
---